Two nutrition companies on opposite sides of the world are becoming one. US-based nutrition startup Berry Street is merging with India's Healthify, in a deal aimed at expanding AI-driven metabolic care, according to reports from Fierce Healthcare and TechCrunch.
According to TechCrunch, Berry Street founder Noah Kotlove and Healthify founder Tushar Vashisht will serve as co-CEOs of the combined entity — an arrangement that signals the merger is being framed as a genuine combination of two businesses rather than one company absorbing the other.
TechCrunch frames the deal against the backdrop of rising GLP-1 usage. GLP-1 drugs, the class that includes widely used weight-loss and diabetes medications, have reshaped how people approach weight and metabolic health. But the drugs are only part of the picture: patients on them still need nutrition guidance, monitoring, and behavioral support, which is exactly the territory both Berry Street and Healthify occupy.
Fierce Healthcare describes the merger as a move to expand AI metabolic care — meaning software that uses AI to help people manage the diet-and-metabolism side of conditions like obesity and diabetes, rather than leaving that work entirely to human clinicians who are in short supply.
The cross-border structure is notable in itself. Berry Street brings a US footprint, while Healthify brings an India-based operation, giving the merged company reach across two very different healthcare markets and cost structures.
Why it matters: as GLP-1 drugs push millions of people into long-term metabolic treatment, the companies that can deliver affordable nutrition support at scale — with AI doing much of the heavy lifting — stand to become an important layer of everyday healthcare.